HealthVerity at ISPOR 2025: Solving RWD Challenges in Pharma and HEOR
Thank you to everyone who joined us at ISPOR 2025 in Montreal. Whether you stopped by our booth,...
Thank you to everyone who joined us at ISPOR 2025 in Montreal. Whether you stopped by our booth,...
Why data provenance matters for regulatory submissions and clinical trials Regulators increasingly...
This is part three of a three-part series on the essential qualities of claims data for life...
This is part two of a three-part series (read part 1, part 3) on the essential qualities of claims...
This is part one of a three-part series (read part 2, part 3) on the essential qualities of claims...
The problem with Zombie Data—And the critical need for Verified Data In life sciences, where...
Key benefits of real-world lab data for life sciences and pharma Real-world lab results enhance...
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial...
The one constant in healthcare marketing is change, particularly in four key areas: Evolving...
In the evolving world of real-world data (RWD), pharmaceutical companies are increasingly focused...
RWE and HEOR teams face increasing pressure to produce evidence that holds up beyond internal analysis. As real-world data informs decisions subject to external review, expectations for data quality have changed.